Volume 6, Issue 3 (10-2022)
EBHPME 2022, 6(3): 169-187 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ansari M, Takian A, Yazdi-Feyzabadi V. The Challenges of Iran's Pharmaceutical Export: A Qualitative Content Analysis. EBHPME 2022; 6 (3) :169-187
URL: http://jebhpme.ssu.ac.ir/article-1-400-en.html
URL: http://jebhpme.ssu.ac.ir/article-1-400-en.html
Department of Health Management, Policy and Economics, Faculty of Management and Medical Information Sciences, Kerman University of Medical Sciences, Kerman, Iran , va_yazdi@kmu.ac.ir
Abstract: (1319 Views)
Background: Development of non-oil exports, including pharmaceutical products is one of the most important economic development strategies. This study aims to explain challenges of pharmaceutical export in Iran by using the sources and content of online media news.
Methods: This was a qualitative study which analyzed the content of general and specialized online media news in Iran (conventional approach) from January 20, 2017 to January 20, 2020. Data sources were selected using the purposive sampling method .Then, the eligible news was determined by quota sampling method and was inductively analyzed in MAXQDA10.
Results: The identified challenges were divided into five main categories including the domestic market of medicines, pharmaceutical manufacturing, financing, marketing and diplomacy. The most important challenges were related to financing and marketing.
Conclusion: Iran's position regarding worldwide export of drugs is not satisfactory. The target markets for drug exports should be developed using a national economic program and appropriate diplomacy, in addition to improving the quality of drug production.
Methods: This was a qualitative study which analyzed the content of general and specialized online media news in Iran (conventional approach) from January 20, 2017 to January 20, 2020. Data sources were selected using the purposive sampling method .Then, the eligible news was determined by quota sampling method and was inductively analyzed in MAXQDA10.
Results: The identified challenges were divided into five main categories including the domestic market of medicines, pharmaceutical manufacturing, financing, marketing and diplomacy. The most important challenges were related to financing and marketing.
Conclusion: Iran's position regarding worldwide export of drugs is not satisfactory. The target markets for drug exports should be developed using a national economic program and appropriate diplomacy, in addition to improving the quality of drug production.
Type of Study: Original article |
Subject:
Health Policy
Received: 2022/06/2 | Accepted: 2022/10/18 | Published: 2022/10/18
Received: 2022/06/2 | Accepted: 2022/10/18 | Published: 2022/10/18
References
1. TORREYA. The future of the global pharmaceutical industry. the United States: 2017.. Available from URL: https://www.trademap.org/Index.aspx. Last access: 7 Septamber, 2021.
2. Trade Map. List of products at 2 digits level exported in 2020. 2021 [updated 2021/09/07]. Available from URL: https://www.trademap.org/ Index.aspx. Last access: 7 Septamber, 2021.
3. Ara research center. Strategic analysis of the country's pharmaceutical industry. Tehran: Payam Resan e Kherad va Andishe Institute, 2018.
4. Shabaninejad H, Yusefzadeh H, Mehralian G, Rahimi B. The structure of the world pharmaceutical market: Prioritizing Iran’s target export markets. Iranian journal of pharmaceutical research: IJPR. 2019; 18(1): 546-55.
5. Yusefzadeh H, Rezapour A, Lotfi F, Azar FE, Nabilo B, Gorji HA, et al. A study of comparative advantage and intra-industry trade in the pharmaceutical industry of Iran. Global Journal of Health Science. 2015; 7(6): 295-307.
6. Basak S. Pharmaceutical market and regulatory contents for export of pharmaceutical products to Latin American countries. IOSR J Pharm. 2018; 8(4): 60-72.
7. The South African Institute of International Affairs (SAIIA). Nigeria and the BRICs: Diplomatic, trade, cultural and military relations. South Africa: 2011.
8. Desa U. Transforming our world: The 2030 agenda for sustainable development. United Nations, 2016.
9. Advocates for International Development. SDG 3: Good health and well-being, A legal guide. London, United Kingdom: Advocates for International Development (A4ID), 2019.
10. Law of the Sixth Five-Year Plan for Economic, Social and Cultural Development of the Islamic Republic of Iran, 2017-2021, (2016).
11. Plan and Budget Organization. Summary of the implementation report of the law of the Sixth Economic, Social and Cultural Development Plan of the Islamic Republic of Iran in 2018. Plan and Budget Organization, 2019.
12. Food and Drug Organization. Drug export regulations. Food and Drug Organization of Iran, 2019.
13. Parliament of Islamic Republic of Iran. General policies of Article 44 of the Constitution of the Islamic Republic of Iran. 2008.
14. Aghlmand S, Rahimi B, Farrokh-Eslamlou H, Nabilou B, Yusefzadeh H. Determinants of Iran’s bilateral intra-industry trade in pharmaceutical industry. Iranian Journal of Pharmaceutical Research: IJPR. 2018; 17(2): 822-8.
15. Ghaedi M, Golshani A. Content analysis method: From quantity-orientation to quality-orientation. Psychological Methods and Models. 2016; 7(23): 57-82. [In Persian]
16. Macnamara JR. Media content analysis: Its uses, benefits and best practice methodology. Asia Pacific Public Relations Journal. 2005; 6(1): 1-34.
17. Tabrizi M. Qualitative content analysis from the perspective of deductive and inductive approaches. Social Science Quarterly. 2014; 21(64): 105-38. [In Persian] [DOI: 10.22054/qjss.2014.344]
18. Iman MT, Noshadi MR. Qualitative content analysis. Pazhuhesh. 2011; 3(2): 15-44.
19. Farhangi AA, Rastegar A. Media content analysis: A research approach. Journal of Media. 2015; 26(3): 121-42. [In Persian]
20. Hsieh H-F, Shannon SE. Three approaches to qualitative content analysis. Qualitative Health Research. 2005; 15(9): 1277-88. [DOI: 10.1177/1049732305276687]
21. Lincoln YS, Guba EG. But is it rigorous? Trustworthiness and authenticity in naturalistic evaluation. New Directions for Program Evaluation. 1986; 1986(30): 73-84. [DOI: 10.1002/ev.1427]
22. Jaberidoost M, Olfat L, Hosseini A, Kebriaeezadeh A, Abdollahi M, Alaeddini M, et al. Pharmaceutical supply chain risk assessment in Iran using Analytic Hierarchy Process (AHP) and Simple Additive Weighting (SAW) methods. Journal of Pharmaceutical Policy and Practice. 2015; 8(1): 9. [DOI: 10.1186/s40545-015-0029-3]
23. Nouraei Motlagh S, Hadian M, Mousavi A, Alipour S, Jahangiri R, Rostami MA. Investigating the effects of exchange rate fluctuations on the import and export of medicine in Iran from 2001 to 2014. Shiraz E-Medical Journal. 2018; 19(10): e66512. [DOI: 10.5812/semj.66512]
24. Aggarwal R, Chen X, Yur-Austin J. Currency risk exposure of Chinese corporations. Research in International Business and Finance. 2011; 25(3): 266-76.
25. Seyedifar M, Nikfar Sh, Abdollahi-Asl A, Rasekh HR, Ehsani A, Kebriaeezadeh A. An evaluation of policies and procedures of successful pharmaceutical exporters and the comparison of Iranian counterpart policy. Journal of Pharmacoeconomics and Pharmaceutical Management. 2015; 1(3/4): 39-44.
26. Asl Roosta R, Moghaddasi R, Hosseini SS. Export target markets of medicinal and aromatic plants. Journal of Applied Research on Medicinal and aromatic Plants. 2017; 7: 84-8. [DOI: 10.1016/j.jarmap.2017.06.003]
27. Karim MH, Karbasi A, Mohamadzadeh SH. Marketing strategies and export of Iranian medicinal plants. Journal of Medicinal Plants and By-product. 2020; 9(1): 101-11. [DOI: 10.22092/JMPB.2020.122080]
28. Barbosa DME, Ayala AH, Sandoval AA. The Colombian pharmaceutical industry: Factors affecting export. European Journal of Management and Business Economics. 2016; 25(2): 39-46. [DOI: 10.1016/j.redee.2015.10.004]
29. Anesary M, Wadud A, Hossain M, Mamun M, Al R, Salam M, et al. Pharmaceutical sector of Bangladesh: Prospects and challenges. BRAC University, 2014.
30. Setayesh S, Mackey TK. Addressing the impact of economic sanctions on Iranian drug shortages in the joint comprehensive plan of action: Promoting access to medicines and health diplomacy. Globalization and Health. [DOI:10.1186/s12992-016-0168-6]
31. Kapuśniak A, Caban A, Rémuzat C, Toumi M. PHP152-Mechanisms of illegal export causing drugs shortages in Poland. Value in Health. 2018; 21: S176. [DOI: 10.1016/j.jval.2018.09.1046.]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
